MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Insys Therapeutics Company Profile (NASDAQ:INSY)

Consensus Ratings for Insys Therapeutics (NASDAQ:INSY) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $43.00 (157.33% upside)

Analysts' Ratings History for Insys Therapeutics (NASDAQ:INSY)
Show:
DateFirmActionRatingPrice TargetActions
2/1/2016RBC CapitalLower Price TargetOutperform$49.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2016Piper JaffrayReiterated RatingOverweight$49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016RBC CapitalReiterated RatingOutperform$49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Jefferies GroupReiterated RatingBuy$36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2015RBC CapitalReiterated RatingOutperform$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Piper JaffrayReiterated RatingBuy$48.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2015Piper JaffrayReiterated RatingBuy$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015Jefferies GroupReiterated RatingBuy$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015OppenheimerReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015OppenheimerReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/16/2015Piper JaffrayReiterated RatingBuy$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015Piper JaffrayReiterated RatingBuy$38.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Jefferies GroupReiterated RatingBuy$63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015OppenheimerReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015Jefferies GroupSet Price TargetBuy$63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2015OppenheimerReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2015RBC CapitalBoost Price TargetOutperform$65.00 -> $71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2015RBC CapitalBoost Price TargetOutperform$57.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2015Jefferies GroupBoost Price TargetBuy$51.00 -> $63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2014Piper JaffrayBoost Price TargetOverweight$51.00 -> $64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014RBC CapitalBoost Price TargetOutperform$53.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/8/2014Jefferies GroupInitiated CoverageBuy$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2014RBC CapitalBoost Price TargetOutperform$51.00 -> $53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2014OppenheimerDowngradeOutperform -> Market Perform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2014Piper JaffrayInitiated CoverageOverweight$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014RBC CapitalInitiated CoverageOutperform$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2014OppenheimerBoost Price Target$30.67 -> $58.67View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2014JMP SecuritiesBoost Price TargetOutperform$33.33 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/10/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha